News for hackers. Stuff that matters.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by risyachka on Friday November 13, 2026 @09:37AM (#50484155)
His statements are based on belief that AI will advance a lot and quickly.

If this happens to be the case - I personally don't see why those statements are not realistic.

All diseases are engineering problems. The bottleneck there is testing etc. Most likely many of them can be cured using existing approach or meds.

Companies grow organs now that can be used to speed up iteration.

Even current AI can solve a LOT of tasks if it has quick feedback loop and can verify results. At the end of the day it can brute-force its way to solution.

AIs intelligence is say average human. Even less, whatever. say it will be as a smart human in a few years.

But it is infinitely scalable.

So is it that unrealistic to assume AI can find a correlation on massive amounts of data and figure our what leads to Alzheimers? (where the solution could be not cure but prevention). I don't think so.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by tsimionescu on Friday November 13, 2026 @09:44AM (#50484257)
> Most likely many of them can be cured using existing approach or meds.

A wildly absurd claim, especially for some of the most studied diseases in human history. This has only ever been true for a tiny handful of very specific diseases, such as scurvy, in all of human history. Expecting that cancer can be cured or prevented using already existing drugs that we've just not been noticing is complete quackery.

> Even current AI can solve a LOT of tasks if it has quick feedback loop and can verify results.

IF it has a quick feedback loop. You know what definitely DOESN'T have a quick feedback loop? Research into medicine, and biology in general. It takes raw time to find out what the effects of a substance on an organism are, often weeks or months.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by risyachka on Friday November 13, 2026 @10:12AM (#50484703)
> It takes raw time to find out what the effects of a substance on an organism are, often weeks or months.

So you are saying that it is 100% impossible in the next 10 years to come up with a way to make it much faster? It takes months - sure, can we run 10k versions of this at the same time? this way in a few months we will have massive amount of results never seen before?

"We can't because of this and that" - and this and that is 100% can't be fixed?

Don't forget - a massive amount of diseases have not been cured just because there is no monetary incentive to spend time on them for big pharma.

If AI brings cost down - does not matter how - could be just because it makes custom software or automates some workflows etc - this alone can open a bunch of opportunities.

Whatever is not solved yes - often is not solved just because enough resources has been thrown at it.

And diseases is just like everything else. They will be cured only if there is financial incentive (or the ratio of cost to revenue changes).

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by tsimionescu on Friday November 13, 2026 @10:19AM (#50484826)
The responses here are not about claims like "Claude will probably help speed up medical research significantly in the next 10 years, and maybe help with finding cures for many obscure diseases".

The responses are to the CEO of Anthropic claiming that "Cancer, heart disease, Alzheimer's, and mental illness will be relics of the past in less than a decade". None of these is some obscure disease that is not getting the funding it needs.

> It takes months - sure, can we run 10k versions of this at the same time? this way in a few months we will have massive amount of results never seen before?

No, you can't - because you're not going to find 100k patients with a certain strain of cancer that you can run 10k parallel trials of different drugs on. To the extent that research can scale, it is already being handled at the higher possible scales, for most of the major diseases.

> Don't forget - a massive amount of diseases have not been cured just because there is no monetary incentive to spend time on them for big pharma.

Yes - but almost exclusively for diseases that affect a very small amount of people each. Making it even more impossible to scale out testing, for the simple fact that only a small amount of victims of the disease even exist.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by risyachka on Friday November 13, 2026 @10:52AM (#50485312)
>> No, you can't

You can't right now.

10 years ago organoids were not a thing. They are now. Can it be another similar development happens in next few years that will allow to create more complex artifical biological systems? Don't see why not.

If that happens can we speed up trial time by orders of magnitude so human trials start only when there is proven much higher level of confidence?

I bet we can

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by tsimionescu on Friday November 13, 2026 @11:04AM (#50485515)
This is continuing the absurdity - at least when talking about Alzheimer's, mental illness, and the more systematic cancers. There is no way whatsoever that we'll develop artificial biosystems that have any real hope of demonstrating pathologies of the human brain good enough to help with drug development in the next few years, and likely even decades - and even less so to make them cheaply enough to scale at some huge scale that makes brute force approaches viable.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by datsci_est_2015 on Friday November 13, 2026 @09:46AM (#50484280)
Speculation of this magnitude is meaningless because you can invoke literally any utopian or dystopian future and everything in-between.

Compute with the power to solve literally any medical issue is also compute that can create bioweapons that instantly kill any human.

Might as well fart into the microphone, in my humblest opinion.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @11:23AM (#50485787)
With that in mind, maybe the guardrails Anthropic put into place for biology make some sense.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by miltonlost on Friday November 13, 2026 @09:55AM (#50484451)
All this boils down to is "yes, believe the man behind the curtain."
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by risyachka on Friday November 13, 2026 @10:13AM (#50484721)
this boils down to humanity solves more and more complex problems with the evolution of technology.

AI is clearly a very capable new tech. Obviously there will be a lot of consequences downstream in 10 years.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by jacquesm on Friday November 13, 2026 @12:28PM (#50486718)
But that is a completely different claim from the highly specific claim that Cancer, Mental Illness and Alzheimers are going to be cured. The reason those three are picked is because they open wallets.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by kunai on Friday November 13, 2026 @09:57AM (#50484481)
One of the greatest issues with the tech culture broadly (and it's been festering for some time) is the belief, almost sacrosanct, that the epistemological set of knowledge that technologists and computer scientists have is able to be extrapolated broadly to every profession and field and that hard issues in a field like biology are obviously solved because OpenAI brute forced a few mathematical proofs. It doesn't work like that. Much of this comment reads like a sci-fi wet dream divorced from reality entirely.

The architecture of ML as it currently stands does assist us in modeling things like protein folding. But that's what they are; models. And before some person chimes in by saying "look how the AI pessimists move the goalposts", see my first point. Biological systems have high entropy and discoveries in biology often do not follow from preexisting discoveries whatsoever and are completely novel. Barring some quantum leap in ML design and architecture you cannot predict stochastically or deterministically how exactly a new enzyme will function in vivo. There is absolutely no evidence that Anthropic has solved this, even if they gobbled up every ML tool used in drug design and trained their models on every biomolecule known to man, it would not work because of fundamental gaps in what can be observed. They are a for-profit company trying to juice their IPO.

Now could LLMs and ML potentially speed up the pace of this research? Absolutely. But it's like saying a Formula 1 car is faster than a NASCAR. Yes, one is very clearly faster, but it's not as if the NASCARs are slow.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @10:02AM (#50484571)
Amodei has a PHD in biophysics and he researched cancer biomarkers at Stanford; it's not like he doesn't know what he's talking about.

You can make the argument that Amodei is dishonest or that he suffers from psychosis.

However, he has made no claims that Anthropic has solved this, and expressing a hope to solve this in the next 5-10 years is hardly fraudulent.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by disgruntledphd2 on Friday November 13, 2026 @10:30AM (#50484986)
> Amodei has a PHD in biophysics and he researched cancer biomarkers at Stanford; it's not like he doesn't know what he's talking about.

That's why I think that something is very weird with his statements. Like, how would this even work?

The feedback loop is much, much, much too slow right now for AI to make things better.

Like, step 1 is build a digital model of the human organism. If you can do this, then yeah maybe the rest is possible. But step 1 is incredibly hard, so it feels unlikely.

That being said, I think the stimulants hypothesis upthread may be correct, as I've heard a lot of crazy stuff from friends on them.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @10:47AM (#50485231)
Of course Opus 5.5 is not going to help build a digital model of the human organism.

If we linearly interpret the last year of progress from GPT-5 to Opus 5.5, times 5x, assuming no plateau, could such an intelligence realistically achieve a task like that?

Maybe also not, perhaps some form of RSI would need to deliver accelerating progress.

There are a lot of assumptions and speculation here. Still, at the end of the day, it does not seem that unlikely that they succeed in creating AI that can reason over so many parameters as to remove all intellectual bottlenecks from the process, leaving mainly the physical limitations.

And what is the limit there to building a good model of the human organism? I won't pretend that I know, but simply pointing to clinical trials, as some here do, instead of making an argument based on how such a digital model cannot be created seems unserious.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by solyin on Friday November 13, 2026 @10:43AM (#50485172)
As a random Internet commenter I can express an honest Ernest fervent hope that we'll solve cancer/etc and get fusion working on the next 5-10 years and there's no fraud. If I make that same claim while trying to get you to buy shares of my company at IPO that's a bit stickier. Companies making claims of wireless transmission of radio waves from NYC to London were sued for fraud, though one was ultimately successful at that. What material non-public information Dario has, we don't know. If he's sitting on information that makes it seem like it's not possible that is fraud. If he's sitting on tech that can simulate a human brain well enough to shorten the feedback loop in order to make that claim but doesn't want to make the claim publicly (GPU compute being semi-general purpose vs eg ASIC Bitcoin miners) that would be very exciting but if he's wildly guessing at the capabilities that AI could do in 5-10?years, that's another.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @10:49AM (#50485268)
My bet would be wild speculation, maybe based in some research they are doing.

I don't think they are holding anything back in revolutionary results or internal models, a week before the IPO.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by datsci_est_2015 on Friday November 13, 2026 @11:07AM (#50485562)
Credentials are just credentials. I've met plenty of cranks with impressive credentials. He doesn't even have to be dishonest or suffer from psychosis - you may just be putting far too much weight into his credentials, a mistake that is frequently made.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @11:14AM (#50485659)
How is that a mistake that is frequently made? The opposite is the case.

People are routinely claiming that as someone in tech, Amodei lacks credibility on biology and has no idea about science.

I'm yet to see someone claim his academic credentials validate his predictions.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by datsci_est_2015 on Friday November 13, 2026 @01:35PM (#50487788)
> How is that a mistake that is frequently made? The opposite is the case.

I wasn't talking about Amodei specifically, but in general: my take is that overweighting credentials is probably the number one mistake that is made in evaluating whether a complete stranger is qualified to do something or not, especially in positions of power.

If you gather 500 PhDs and put them in one room, and 500 individuals without post-secondary education in another, give them all a quiz, I'm sure that the former room will outperform the latter room on average. Pick one of those 500 PhDs at random and I can probably find a topic where they're completely out of their depth, and perhaps even arrogantly so: https://en.wikipedia.org/wiki/Nobel_disease

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by jcranmer on Friday November 13, 2026 @10:14AM (#50484742)
> So is it that unrealistic to assume AI can find a correlation on massive amounts of data and figure our what leads to Alzheimers? (where the solution could be not cure but prevention). I don't think so.

Yes. The mistake you're making here is that you're not understanding where the actual bottlenecks are in drug development, and why some targets like Alzheimer's have been so elusive.

The problem with Alzheimer's in particular is that we don't have a working model of how Alzheimer's works. The dominant model--the amyloid hypothesis--can pretty conclusively be chucked in the bin at this point because of the number of amyloid clearing drugs that just simply have no effect on the progression of Alzheimer's, but there's no model that actually looks any better. Without a proven model, the only to verify effectiveness of an Alzheimer's drug is try it out in humans [1] and wait several years to get a success-or-no-success readout. That's the rate-limiting step for Alzheimer's drugs.

Okay, so maybe you're going to suggest that we can use AI to come up with new Alzheimer's models. Okay, but the rate-limiting step is still proving those models, which because of the human-only nature of Alzheimer's, requires developing the drugs and testing them and you're going to wait a decade to get back your answer as to whether or not the theory was correct. And what data are you going to use? If you're trawling scientific literature, you're going to come up with only the same ideas people have already had for alternative Alzheimer's models (there are a lot of those). If you're trawling medical data, well, medical data just doesn't exist in the level of detail you need for that enterprise, and handwaving away the legal issues with collecting it, it would still take years just to collect that data (and probably still not be good quality!).

[1] There's another complication of Alzheimer's, which is that only humans get Alzheimer's, so we can't even do anything like testing in animals with shorter lifespans to speed this part up.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by Windchaser on Friday November 13, 2026 @11:23AM (#50485783)
And the thing is, I fundamentally agree with the guy above you that all of these problems can be solved, that we can sidestep the bottlenecks and move faster.

But it requires tools that we are nowhere even close to having. One way would be to build a ground-up, molecules-to-man model of how the body works. And then from there, sure, we can easily model how Alzheimer's might come about and how it might be cured. Like, with tremendous advancements we might be able to finish such a project this century. In the next decade? That's like saying we'll launch an expedition to Alpha Centauri in a decade.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @11:50AM (#50486174)
Amodei in 2024 wrote about compressing research that would take biologists 100 years into 10, so that checks out.

Given that he was making these projections already long before today, it would be fair to say that it's speculative rather than based on current research progress.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by jacquesm on Friday November 13, 2026 @11:53AM (#50486223)
You could write that. But it doesn't actually mean anything, and it would be better to assume that biologists with tools will move faster on biology but that does not necessarily translate into things that have to do with medicine which is something else entirely.
Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @12:10PM (#50486487)
I am not surprised that you would think that AI will be merely a tool that allows biologists to move somewhat faster, rather than make discoveries or control research.

Because I remember that you shared similar opinions about software where you cited liability as a limitation that for you precludes more autonomous use of AI.

I think it's safe to say that you have an entirely different expectation for how AI will progress and how it will be used, or at least that was my impression.

With the release of Fable 5.2, I have to say that you might be right. Maybe progress is already slowing down, it certainly isn't as big a step as I was hoping to see after Opus 5.5.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by jacquesm on Friday November 13, 2026 @12:38PM (#50486891)
> Because I remember that you shared similar opinions about software where you cited liability as a limitation that for you precludes more autonomous use of AI.

Shall we wait until that trajectory has run its course before we start claiming victory?

As for the rest of this discussion:

Medicine != computer science, math or physics. Biology isn't either. The degree of complexity is many orders of magnitude higher.

Curing cancer : very unlikely, cancer is a systemic issue that requires many mechanisms in the body to do its thing, most of which we also require to stay alive. Short of a massive breakthrough in nano technology curing cancer is stupendously hard and it would be proof of reaching an entirely different plateau of capabilities for Humanity as a whole. Besides that, it isn't cancer that kills the most people on the planet, it is hunger, and then climate change.

The second one: Curing mental illness. I think it is equally delusional to be able to claim that you can cure mental illness because mental illness is a very broad description, so broad that it covers a wide variety of issues with an even wider variety of root causes the bulk of which are not well understood. Our brains are hard to appreciate in terms of capabilities and it shouldn't be surprising that something so compact and so powerful can break. Whether you can repair it after it breaks is not something you can say with certainty in the present unless you can demonstrate structural progress in the field compared to where it was say five years ago. To the best of my knowledge this is not the case.

Finally, Alzheimers. This is another one of those 'too good to be true' things. Alzheimers is next to cancer one of the diseases that has been studied extensively without much progress as to both root causes and cures. That doesn't mean that we won't find one, but here too: you would have to show at least incremental progress and to show a number of very promising leads that we didn't have so far to be able to make this claim.

In short: this is a marketing ploy, these three were picked because they hit everybody, either directly or indirectly. What they are saying is 'imagine, if we had this AI that we are working on today the problems that affect you or your loved ones would no longer exist'. This kind of promise is known to open the wallets of the gullible.

It is also fraudulent.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @12:50PM (#50487097)
If anything I ceded some ground there rather than claiming victory.

Before I really change my mind, what would need to happen is little progress in AI until say March. Then I will really worry about progress slowing down and plateauing.

I am under the impression that Amodei sincerely believes in what he says, which has long been an acceleration of biomedical research to cure most major disease.

That he recently picked these specific diseases in order to essentially defraud investors is a large stretch.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by jacquesm on Friday November 13, 2026 @12:54PM (#50487176)
Lots of people sincerely believe what they are saying. Some of those people may ultimately be right. But expertise in one domain rarely translates into another and even though AI is a 'universal tool' (just like regular intelligence) the chances of the new broom sweeping cleaner are high simply because the broom has a different shape and is working very fast. But that does not immediately translate into fantasy land 'wouldn't it be great if' promises coming true.

In fact I think Amodei is making a massive mistake here: you can make these promises, but they will be remembered. And when you ultimately fail - which is highly likely - it will look like you oversold your IPO and that's actionable. AI already has plenty of potential without talking about curing cancer, mental illness or Alzheimers, those claims should come from the specialists in those fields using AI as a tool.

It's akin to IBM saying they're going to put all of the banks and insurance companies out of business in 1950. Yes, computers back then were seen as just as revolutionary as we see AI today. It did transform the world, I give you that. But IBM ended up as 'just another company' and I suspect that the same will hold for OpenAI and Anthropic for many different, mutually reinforcing reasons.

edit: to address your last line: I don't think it is a stretch at all: if you think it is, show me the proof, show concrete progress that Anthropic has made in any of those three fields that warrant these statements. If you can't then you'll have to concede they are highly speculative at best and that's not what you do when you are about to take public money.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by user43928 on Friday November 13, 2026 @01:15PM (#50487479)
I think the projections must be entirely speculative, as they are from Amodei's 2024 essay rather than recent results.

When we talk about fraud, I think it's important that these clearly are not promises. In 2024 he specifically said: "Everything I’m saying could very easily be wrong".

His recent statements, including the one we see here in OP's video, say 'I believe' or 'I think', not that Anthropic claims to solve this by that deadline.

Perhaps he is overpromising or wildly speculating, sure, but I am not convinced that this is fraudulent or criminal at all; that said, I did not look into the legality of it.

Re:Eli Lilly CEO pushes back on Dario Amodei's ludicrous med... by BigTTYGothGF on Friday November 13, 2026 @03:03PM (#50488900)
Tell it to the LTEE.